47045-SLE-Z-WVI-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria Sierra Leone, Multicomponent, World Vision International Goals: Reduction of new HIV infections; Reduction of AIDs related mortality; Elimination of HIV related stigma and discrimination; TB case detection rate is increased by 15% through active case finding, integration of TB in other services, involvement of Private sector, and expansion of use of Gene-Xpert test, and 90% of Drug Susceptible TB cases notified & treated by 2025; Increase access to laboratory and TB diagnostic services from 50% of the existing Community Health Centers (CHCs) and from 59% of the functional hospitals to 80 % by 2025; Detect and diagnose 90% of the MDR-TB cases and treat with appropriate therapy by 2025; By the end of 2025, contribute significantly to the improvement of the well-being of the population by reducing the malaria burden. Objectives: High Impact Interventions; Three Zeros: Continued guidance by the sustainable development goals (SDGs) as informed by the global UNAIDS 2016-2021 Strategy aimed at eliminating new infections, stigma and AIDS related deaths; The 90-90-90 targets: the at least 90-90-90 (or 95-95-95) targets for the testing and knowledge of sero status; linkages to and enrolment to care and treatment and; retention in treatment and care for the Persons Living with HIV; Differentiated Service Delivery (DSD) and access to effectively reach all the population groups, geographical areas, social strata and navigate the social normative, legal and human rights framework settings and landscape; Conduct active and intensified TB case finding; Build the capacity of HCWs to improve quality of TB care and address districts wide disparities in TB treatment success rate (TSR); Reach TB patients in areas hard to reach areas; By the end of 2025, reduce malaria mortality rates by at least 75% compared to 2015; By the end of 2025, reduce malaria case incidence by at least 75% compared to 2015; By 2025, 90% of the population practice at least 3 recommended malaria prevention and control behaviours; To strengthen malaria surveillance and use of malaria information to improve decision-making for programme performance; Ensure timely and adequate supply of quality-assured malaria commodities to public and private health facilities at all levels by 2025. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International World Vision International The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Blanca Gil Antunano Vizcaino Fund Portfolio Manager +41 58 791 1700 blanca.gilantunanovizcaino@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Sierra Leone Multicomponent, RSSH HIV Malaria Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Differentiated HIV Testing Services -> Community-based testing outside of KP and AGYW programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Prevention of incident HIV among pregnant and breastfeeding women HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Community empowerment for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> HIV prevention communication, information and demand creation for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM HIV -> Prevention package for other vulnerable populations (OVP) -> HIV prevention communication, information and demand creation for OVP HIV -> Prevention package for people in prisons and other closed settings -> HIV prevention communication, information and demand creation for prisoners HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Needle and syringe programs for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Opioid substitution therapy and other medically assisted drug dependence treatment for PWID HIV -> Prevention package for sex workers, their clients and other sexual partners -> Community empowerment for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programming for sex workers HIV -> Prevention package for transgender people and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for transgender people HIV -> Reducing human rights-related barriers to HIV/TB services -> Community mobilization and advocacy for human rights HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring rights-based law enforcement practices HIV -> Reducing human rights-related barriers to HIV/TB services -> Improving laws, regulations and policies relating to HIV and HIV/TB HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights") (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) Malaria -> Specific prevention interventions (SPI) -> Social and behavior change (SBC) (Specific prevention interventions) Malaria -> Vector control -> Insecticide treated nets (ITNs) - Mass campaign: universal Multicomponent -> Program management -> Grant management RSSH -> RSSH/PP: Human resources for health (HRH) and quality of care -> RSSH/PP: Quality improvement and capacity building for quality of care RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Quality management systems and accreditation RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development RSSH -> RSSH: Community systems strengthening -> Community engagement, linkages and coordination RSSH -> RSSH: Community systems strengthening -> Community-led monitoring RSSH -> RSSH: Community systems strengthening -> Community-led research and advocacy RSSH -> RSSH: Health products management systems -> Planning and procurement capacity RSSH -> RSSH: Health products management systems -> Regulatory/quality assurance support RSSH -> RSSH: Health products management systems -> Storage and distribution capacity, design & operations RSSH -> RSSH: Health products management systems -> Supply chain information systems Tuberculosis -> Collaboration with other providers and sectors -> Community-based TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions 2141217.20 8572949.78 9686222.88 3537075.70 12175628.76 Global Fund commitment to SLE-Z-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 2252070.00 Global Fund disbursement to SLE-Z-WVIP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 2381898.00 Global Fund disbursement to SLE-Z-WVIP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 874157.00 Global Fund disbursement to SLE-Z-WVIP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 2017234.00 Global Fund disbursement to SLE-Z-WVIP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 1874668.00 Global Fund disbursement to SLE-Z-WVIP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 1569708.02 Global Fund disbursement to SLE-Z-WVIP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International -1205893.74 Global Fund commitment to SLE-Z-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 0.00 Global Fund commitment to SLE-Z-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 10566744.77 Global Fund commitment to SLE-Z-WVIP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 806122.65 Global Fund disbursement to SLE-Z-WVIP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 1267436.34 Global Fund disbursement to SLE-Z-WVIP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria World Vision International 2141217.00 Expenditure reported by World Vision International for SLE-Z-WVIP01, Jul 2024 to Dec 2024. World Vision International 6710292.71 Expenditure reported by World Vision International for SLE-Z-WVIP01, Jan 2025 to Dec 2025. World Vision International An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Funding Request of funding request FR1544-SLE-Z. 1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. 2 - Right of Access With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation. 3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 18,966,701 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.4(1)(a) and 5.4(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) maintain or domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in in the letter from the Ministry of Finance of the Republic of Sierra Leone dated 2 February 2024 (the “Commitment Letter”), unless otherwise agreed in writing with the Global Fund: (a) fulfil a total minimum co-financing commitment of USD 6,745,941 from 2024-2026 (inclusive), comprising investments in: i. HIV of USD 316,101; ii.TB of USD 238,077; iii. Malaria of USD 631,439; and iv. RSSH of USD 5,560,322; (b) fulfil the programmatic commitments as stipulated in Section 1.3 of the Commitment Letter; and (c) provide to the Global Fund, by no later than 30th June of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for HIV / TB / Malaria / RSSH for the upcoming year; and ii. the total expenditure for HIV / TB / Malaria / RSSH in the previous fiscal year; and iii. evidence of government financial bond release as co-financing towards construction of a pharma-grade warehouse. 4 - Notwithstanding that the Program budget includes USD 1,254,000 (the Breaking Down Barriers Budget) earmarked for activities to support scaling up programs to remove human rights and gender-related barriers (the Catalytic Priority), the Principal Recipient acknowledges that access to USD 800,000 of the the Breaking Down Barriers Budget is subject to the Principal Recipient identifying and reinvesting, to the Global Fund's satisfaction, an additional USD 1,045,927.52 of Grant Funds towards the Catalytic Priority by no later than 31 March 2025. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 5557; Denominator: 20000. Numerator: 1548; Denominator: 22114. Numerator: 2269; Denominator: 22114. Numerator: 2010; Denominator: 21496. Numerator: 5526; Denominator: 21496. Numerator: 1548; Denominator: 22114. Numerator: 2010; Denominator: 21496. Numerator: 5526; Denominator: 21496. Numerator: 2010; Denominator: 21496. Numerator: 3018; Denominator: 25150. Numerator: 3018; Denominator: 25150. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 1046; Denominator: 1700. Numerator: 591; Denominator: 9850. Numerator: 2868; Denominator: 9850. Numerator: 591; Denominator: 9850. Numerator: 822; Denominator: 9619. Numerator: 6106; Denominator: 9736. Numerator: 822; Denominator: 9619. Numerator: 6106; Denominator: 9736. Numerator: 822; Denominator: 9619. Numerator: 986; Denominator: 11532. Numerator: 1346; Denominator: 11217. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 40839; Denominator: 240000. Numerator: 9888; Denominator: 39552. Numerator: 10099; Denominator: 39552. Numerator: 9888; Denominator: 39552. Numerator: 13843; Denominator: 39549. Numerator: 16763; Denominator: 39549. Numerator: 13843; Denominator: 39549. Numerator: 16763; Denominator: 39549. Numerator: 13843; Denominator: 39549. Numerator: 18984; Denominator: 47460. Numerator: 18984; Denominator: 47460. Module: Prevention package for men who have sex with men (MSM) and their sexual partners. Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 12936; Denominator: 20000. Numerator: 3439; Denominator: 21494. Numerator: 2270; Denominator: 21494. Numerator: 3654; Denominator: 21494. Numerator: 6164; Denominator: 21494. Numerator: 3439; Denominator: 21494. Numerator: 3654; Denominator: 21494. Numerator: 6164; Denominator: 21494. Numerator: 3654; Denominator: 21494. Numerator: 4643; Denominator: 25794. Numerator: 4643; Denominator: 25794. Module: Prevention package for people who use drugs (PUD) and their sexual partners. Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 1156; Denominator: 1749. Numerator: 2492; Denominator: 9585. Numerator: 2510; Denominator: 9585. Numerator: 2492; Denominator: 9585. Numerator: 3213; Denominator: 9736. Numerator: 6747; Denominator: 9736. Numerator: 3213; Denominator: 9736. Numerator: 6747; Denominator: 9736. Numerator: 3213; Denominator: 9736. Numerator: 4721; Denominator: 11515. Numerator: 4721; Denominator: 11515. Module: Prevention package for sex workers, their clients and other sexual partners. Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 95283; Denominator: 240000. Numerator: 16373; Denominator: 39934. Numerator: 11106; Denominator: 39934. Numerator: 16373; Denominator: 39934. Numerator: 16690; Denominator: 39549. Numerator: 22973; Denominator: 39549. Numerator: 16690; Denominator: 39549. Numerator: 22973; Denominator: 39549. Numerator: 16690; Denominator: 39549. Numerator: 20435; Denominator: 47523. Numerator: 20435; Denominator: 47523.